The majority of Jordan's pharmaceutical production is exported to foreign markets within the Middle East. Given the downturn in demand for Jordanian medicines, with austerity remaining an overriding theme in much of the region, we expect Jordan will increasingly look to develop new export partners over the coming years. The shifting disease profile towards non-communicable diseases will create further opportunities for high-value innovative drugs. However, these will remain sourced from abroad given the relatively basic nature of local drugmakers' manufacturing capabilities. In absolute terms, Jordan's pharmaceutical market is somewhat overshadowed by neighbouring countries within the Middle East. As such, Saudi Arabia and the UAE dominate pharmaceutical expenditure in the region. However, Jordan still boasts a moderately large pharmaceutical market - surpassing those of Oman, Qatar, Yemen, Bahrain and Syria.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market Overview

Competitive

LandscapeCompany

Profile

Jordan Demographic Outlook Pharmaceuticals & Healthcare Glossary

Pharmaceuticals & Healthcare Methodology